ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Maria Carolina Hinestrosa, EVP of National Breast Cancer Coalition

June 26, 2009

Obituary: Ronald Herberman, 72, UPCI Founding Director

July 3, 2013

ASC Survey Leads to Strategic Plan Development, Office In Washington

June 9, 1989

Patients Report Clinical Trials Not Offered By Physician

June 27, 2008

In Brief: Univ. Of Pittsburgh Creates Genetics Institute; Elion Inducted Into Inventors Hall of Fame

April 5, 1991

ASCO Recommends Against Chemo In Stage II Colon Cancer

June 25, 2004